Adjusting for medication use in GWAS and its impact on Mendelian randomization analyses: an example of systolic blood pressure in UK Biobank
Preprint
Abstract
Medication use is common in large-scale population cohorts, and can modify phenotypic traits of interest. This can potentially bias effect estimates in genome-wide association studies (GWAS) and impact downstream analyses such as mendelian randomization (MR). The best approach to account for medication use in GWAS is unclear. In this study, we compared seven different methods of adjusting for antihypertensive use in a systolic blood pressure (SBP) GWAS of 407,960 White British individuals in the UK Biobank. We found that direct adjustments to measured SBP (adding constants, class-specific constants, censored normal regression) in general yielded a greater number of genome-wide significant variant associations and unmasked stronger GWAS effect estimates than unadjusted measures of SBP. Adjustment for class-specific constants showed the greatest difference relative to unadjusted GWAS. Restriction methods which limit the sample to either untreated individuals or age ranges with low levels of antihypertensive use had less power, due to reduced sample sizes. Effect estimates of treated individuals were deflated relative to untreated individuals, demonstrating the importance of medication adjustment. In MR analyses, we found no substantial differences in inverse-variance weighted (IVW) estimates when using differing exposure GWAS methods in estimation of the effect of SBP on coronary artery disease. Larger variations in IVW estimates were observed for the causal effect of body mass index on SBP across adjustment approaches. In general, the effects of medication use do not substantially affect overall findings. However, bias may arise in MR analyses when the exposure included in the estimation affects the probability of treatment.Keywords
Funding Information
- Wellcome Trust (218495/Z/19/Z)
- Medical Research Council (UKRI077)
- Medical Research Council (MC_UU_00032/1)
- MQ: Transforming Mental Health (MQF22/22)
This publication has 75 references indexed in Scilit:
- Multivariable MR Can Mitigate Bias in Two‐Sample MR Using Covariable‐Adjusted Summary AssociationsGenetic Epidemiology, 2025
- Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomizationStatistics in Medicine, 2021
- 10 Years of GWAS Discovery: Biology, Function, and TranslationThe American Journal of Human Genetics, 2017
- Genetic studies of body mass index yield new insights for obesity biologyNature, 2015
- Adjusting for Heritable Covariates Can Bias Effect Estimates in Genome-Wide Association StudiesThe American Journal of Human Genetics, 2015
- What makes UK Biobank special?The Lancet, 2012
- GCTA: A Tool for Genome-wide Complex Trait AnalysisThe American Journal of Human Genetics, 2011
- Quality Control for Genome-Wide Association Studies2010
- Genome-wide association analysis of metabolic traits in a birth cohort from a founder populationNature Genetics, 2008
- Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressureStatistics in Medicine, 2005